Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Rigel Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 150 institutions reported holding Rigel Pharmaceuticals, Inc., 87.7% of its shares. Largest: BlackRock, Soleus Capital Management, L.P. and Armistice Capital, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Rigel Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 1.94M | 10.4% | +171K | Aug 7, 2026 |
| Soleus Capital Management, L.P. | 1.84M | 9.9% | +1.83M | Aug 11, 2026 |
| Armistice Capital, LLC | 1.67M | 9.0% | +392K | Aug 14, 2026 |
| Vanguard | 1.16M | 6.2% | +103K | Aug 13, 2026 |
| State Street | 1.04M | 5.6% | −80,244 | Aug 7, 2026 |
| American Century | 742K | 4.0% | +197K | Aug 12, 2026 |
| Lsv Asset Management | 722K | 3.9% | +120K | Aug 6, 2026 |
| Acadian Asset Management LLC | 592K | 3.2% | −74,740 | Aug 13, 2026 |
| D. E. Shaw & Co., Inc. | 543K | 2.9% | +96,861 | Aug 14, 2026 |
| Geode Capital | 483K | 2.6% | +42,549 | Aug 12, 2026 |